Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research-Reference-Cited by-同舟云学术

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research

Published:2016-09 Issue:9 Volume:22 Page:1615-1620
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Potter Victoria T.,Iacobelli Simona,van Biezen Anja,Maertens Johann,Bourhis Jean-Henri,Passweg Jakob R.,Yakhoub-Agha Ibrahim,Tabrizi Reza,Bay Jacques-Olivier,Chevallier Patrice,Chalandon Yves,Huynh Anne,Cahn Jean Yves,Ljungman Per,Craddock Charles,Lenhoff Stig,Russell N.H.,Fegueux Nathalie,Socié Gerard,Bruno Benedetto,Meijer Ellen,Mufti G.J.,de Witte Theo,Robin Marie,Kröger Nicolaus

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference22 articles.

1. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia;Fenaux;J Clin Oncol,2010

2. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol,2009

3. Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS;Gerds;Biol Blood Marrow Transplant,2012

4. Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies;Damaj;J Clin Oncol,2012

5. 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation;Field;Bone Marrow Transplant,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

2. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

3. Change is not always good;Blood;2024-07-25

4. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

5. Advances in the management of higher-risk myelodysplastic syndromes: future prospects;Leukemia & Lymphoma;2024-05-07